Prognostic Impact of Cytogenetic Abnormalities On Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated with Thalidomide-Dexamethasone Incorporated Into Double Autologous Stem-Cell Transplantation: An Analysis of 593 Patients
2010; Elsevier BV; Volume: 116; Issue: 21 Linguagem: Inglês
10.1182/blood.v116.21.3562.3562
ISSN1528-0020
AutoresElena Zamagni, Nicoletta Testoni, Carolina Terragna, Paola Tacchetti, M Fiacchini, Francesca Patriarca, Patrizia Tosi, Francesco Di Raimondo, Giulia Marzocchi, Maria Teresa Petrucci, Lucio Catalano, Sandra Durante, Silvestro Volpe, Mónica Galli, Luciano Masini, A Ledda, Annamaria Brioli, Claudia Crippa, Alessandro Gozzetti, Franco Narni, Catello Califano, Claudia Cellini, Sara Bringhen, Giuliana Leopardi, Lucia Pantani, Michela Ceccolini, Massimo Offidani, Giulia Perrone, Beatrice Anna Zannetti, Michele Baccarani, Michèle Cavo,
Tópico(s)Cancer Treatment and Pharmacology
Referência(s)